|
|
||||||||
Technical Innovation |
1 Department of Radiology, The University of Chicago Medical Center, MC 2026,
5841 S Maryland Ave., Chicago, IL 60637.
2 Department of Orthopaedic Surgery and Rehabilitation Medicine, The University
of Chicago Medical Center, Chicago, IL.
Received November 12, 2007;
accepted after revision December 21, 2007.
Address correspondence to R. R. Corby
(rod_corby{at}yahoo.com).
Abstract
|
|
|---|
CONCLUSION. Technical success was achieved in both cases with a prompt clinical response and no treatment-related complications. To our knowledge, this is the first description of the application of radiofrequency ablation for the treatment of solitary eosinophilic granuloma of the bone.
Keywords: bone electrosurgical device eosinophilic granuloma radiofrequency ablation
|
|
|---|
Treatment options are disputed, and the often benign course and spontaneous healing of these lesions are well documented [2, 3]. Many proven and effective therapies exist including wide excision, curettage with or with out bone grafting, intralesional steroids, and local external beam radiation [2-4]. Surgical treatment often entails prolonged recovery and has significant associated morbidities. Advances in imaging-guided intervention offer new options for the treatment of EG of bone.
Radiofrequency ablation involves the application of energy in the radio wave frequency resulting in local thermal coagulative necrosis [5]. In 1992, Rosenthal et al. [6] first described the radiofrequency ablation of osteoid osteoma, for which radiofrequency ablation has become the standard treatment. Radiofrequency ablation has subsequently met success in both musculoskeletal and visceral applications. In this article about our initial clinical experience, we describe the application of radiofrequency ablation for the treatment of EG of bone as a minimally invasive treatment option.
|
|
|---|
A 6-cm, 11-gauge StarBurst access system (RITA Medical Systems) (case 1) or a 10-cm, 11-gauge Osteo-Site bone biopsy needle (Cook Medical) (case 2) was advanced and buried in the cortex under CT guidance. A Bonopty extended drill (C. R. Bard) was then used to bore the cortex to the level of the lesion. A 10-cm (case 1) or 15-cm (case 2) StarBurst XL electrosurgical device (RITA Medical Systems) was then advanced into the center of the lesion under CT guidance and the tines unroofed to the maximum extent allowed by the confines of the cortex of the bone in an attempt to ablate as much of the lesion as possible.
An initial energy application using a RITA Model 1500x generator (RITA Medical Systems) was applied to achieve a temperature of 90°C for 6 minutes. After a cooldown period of 5 minutes, the electrosurgical device was retracted slightly within the lesion to ensure ablation of the portion of the lesion closest to the introducer. A second energy application was applied to achieve a temperature of 90°C for 3 minutes. This was an arbitrary decision based on the assumption that the majority of the lesion, if not the entire lesion, was completely treated during the first ablation. A dressing was applied and the patients were admitted for pain management. The patients were discharged the following day with appropriate analgesia. The orthopedic service instructed the patients to use crutches for 6 weeks and then to bear weight as tolerated by pain. These recommendations were made on the basis of the size of the lesion and involvement of weight-bearing bone.
|
|
|
|
|
|---|
Case 2
A 14-year-old girl was referred from an outside institution, where she
presented with left hip pain and underwent a failed (unable to locate the
target lesion) open biopsy and curettage of a left supraacetabular lesion.
Radiographs at our institution showed a lytic lesion in the left
supraacetabular ilium (Fig.
2A), and a subsequent CT-guided biopsy confirmed the diagnosis of
EG. After a discussion of the treatment options, the patient opted for
minimally invasive radiofrequency ablation. The procedure was performed 2
weeks after presentation (Fig.
2B). The total procedure time was 90 minutes, and there were no
complications. The patient experienced complete resolution of pain 2 days
after the procedure and returned to normal activity levels over the next
several months. Subsequent radiographs 11 months after the intervention showed
progressive healing of the lesion (Fig.
2C).
|
|
|
|
|
|---|
Advances in imaging-guided intervention offer diagnosis and therapy using a minimally invasive percutaneous approach. CT-guided radiofrequency ablation has become the standard of care for the management of osteoid osteoma. Radiofrequency ablation has been reported in the treatment of chondroblastoma, epithelioid hemangioma, chordoma, and metastatic disease [5]. In this article, we describe the novel application of radiofrequency ablation for the treatment of solitary EG of bone.
The decision to treat a lesion percutaneously often depends on the surgeon's preference for obtaining histologic confirmation [7]. In each case presented, a percutaneous CT-guided biopsy was performed for histologic confirmation. Unremitting pain and limitation of activity prompted therapy in both cases. Radiofrequency ablation was chosen with the objective of reducing recovery time and potential postoperative complications and achieving a superior cosmetic result. Additional influences in case 2 were the previous failed surgical attempt and the risks associated with disarticulating the hip with operative management.
Energy in the radiofrequency range applied to an electrode results in local tissue heating that can be used to ablate a controlled volume of tissue [5]. It has been shown that tissue heating to 47°C for 30 seconds causes thermal necrosis of bone [8]. The diameter of coagulation depends on the current, duration of treatment, and local tissue blood flow. The larger size of many EG lesions compared with osteoid osteoma necessitates a larger treatment volume. The Star-Burst XL electrosurgical device we used is an umbrella-type expanding electrode capable of providing treatment volumes up to 3 to 5 cm in diameter when fully unroofed. This allowed treatment with only a single access point. In larger lesions, more ablations may be necessary, possibly with multiple access points.
Radiofrequency ablation is not a suitable alternative for all patients. Treatment of any lesion within 1 cm of a critical neural or visceral (bladder or bowel) structure is contraindicated because of the potential for injury secondary to thermal diffusion. Excessively large lesions may be better suited to surgical therapy, especially in weight-bearing bones. Alternatively, the instillation of cement after radiofrequency ablation may be considered in larger lesions to reduce subsequent fracture risk. Finally, because EG has a variety of imaging appearances and hence may mimic other pathologic processes ranging from infection to malignancy, preablation histologic confirmation is necessary.
The mechanism by which radiofrequency ablation induces osseous remodeling is unknown, and it is unclear if the rate of healing was influenced by treatment in these cases. Previous reports have shown that the rate of resolution is unaffected by the mode of treatment [3]. Reported rates of postintervention healing vary widely, ranging from 3 to 24 months [3, 4, 7]. Our cases fall within this range. Although a definite therapeutic effect cannot be proven, the radiographic response and rapid pain relief support the efficacy of this treatment. We hope this report will generate further research of radiofrequency ablation for the treatment of EG of bone as a minimally invasive alternative to surgery.
|
|
|---|
This article has been cited by other articles:
![]() |
P. L. Munk, D. Malfair, F. Rashid, and W. C. Torreggiani Radiofrequency Ablation of Solitary Eosinophilic Granuloma of Bone Am. J. Roentgenol., December 1, 2008; 191(6): W320 - W320. [Full Text] [PDF] |
||||
![]() |
R. R. Corby, G. S. Stacy, T. D. Peabody, and L. B. Dixon Reply Am. J. Roentgenol., December 1, 2008; 191(6): W321 - W321. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |